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Glossary of Abbreviations 52 
AUC:  area under the receiver operating characteristic curve 53 
CI:  confidence interval 54 
CPR: cardiopulmonary resuscitation 55 
CVICU: cardiovascular intensive care unit 56 
∆Cr:  change in serum creatinine from baseline 57 
ECMO: extracorporeal membrane oxygenation 58 
FiO2: fraction of inspired oxygen 59 
ICU:  intensive care unit 60 
LOS:  length of stay 61 
IQR: interquartile range 62 
MAP: mean airway pressure 63 
OR:  odds ratio 64 
PEEP: positive end expiratory pressure 65 
PIP: peak inspiratory pressure 66 
ROC:  receiver operating characteristic 67 
RR: respiratory rate 68 
STAT category: Society of Thoracic Surgeons-European Association for Cardio-69 
Thoracic Surgery Congenital Heart Surgery mortality category 70 
VI:  ventilation index 71 
VIS:  vasoactive-inotrope score 72 
VVR:  vasoactive-ventilation-renal score 73 
 74 
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 76 
 77 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
Abstract 78 
Objectives:  We aimed to further validate the vasoactive-ventilation-renal score (VVR) 79 
as a predictor of outcome in patients recovering from surgery for congenital heart 80 
disease.  We also sought to determine the optimal time point within the early recovery 81 
period at which the VVR should be measured.  82 
Methods:  We prospectively reviewed consecutive patients recovering from cardiac 83 
surgery within our ICU between 1/2015 – 6/2015.  The VVR was calculated at 6, 12, 24, 84 
and 48 hours postoperatively as follows: VVR = ventilation index + vasoactive-inotrope 85 
score + ∆ creatinine [change in serum creatinine from baseline*10].  Primary outcome of 86 
interest was prolonged hospital length of stay (LOS), defined as LOS in the upper 25%.  87 
Receiver operating characteristic curves were generated and areas under the curve 88 
(AUC) with 95% confidence intervals (CI) were calculated for all time points.  89 
Multivariable logistic regression modelling was also performed. 90 
Results:  We reviewed 164 patients, median age 9.25 months (interquartile range: 2.6 - 91 
58 months).  Median LOS was 8 days (interquartile range: 5 - 17.5 days).  The AUC 92 
value for the VVR as a predictor of prolonged LOS (>17.5 days) was greatest at 12 93 
hours postoperatively, AUC=0.93 (95% CI: 0.89 - 0.97).  On multivariable regression 94 
analysis, after adjustment for potential confounders, the 12-hour VVR remained a strong 95 
predictor of prolonged hospital LOS (OR: 1.15, 95% CI: 1.10, 1.20) 96 
Conclusions:  In a heterogeneous population of patients undergoing surgery for 97 
congenital heart disease, the novel VVR calculated in the early postoperative recovery 98 
period can be a strong predictor of prolonged hospital LOS. 99 
Abstract Word Count: 249 100 
 101 
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Central Message 104 
The vasoactive-ventilation-renal score is a novel measure that robustly predicts outcome 105 
after surgery for congenital heart disease. 106 
 107 
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Perspective Statement 130 
In this prospective study of patients undergoing surgery for congenital heart disease, the 131 
vasoactive-ventilation-renal score obtained 12 hours after ICU arrival was a strong 132 
predictor of clinical outcome.  This novel score could prove to be a powerful tool for 133 
bedside assessment of illness severity and prognosis, triage of ICU resources, and 134 
stratification of clinical research subjects. 135 
 136 
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Central Image 156 
ROC curves for prolonged LOS and the multivariable model (solid) and its individual 157 
components (dashed).  158 
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Introduction  182 
Scoring indices that can accurately reflect the severity of illness in critically-ill patients 183 
can be extremely valuable in contemporary medicine, providing guidance in patient care 184 
(e.g. triage, prognostication) and clinical research (e.g. stratification). The development 185 
of a disease severity index for children recovering from cardiac surgery however has 186 
been somewhat elusive, in large part due to the inherent heterogeneity of anatomy and 187 
pathophysiology within this patient population.  To this end, the novel vasoactive-188 
ventilation-renal (VVR) score has recently demonstrated promise [1,2].  Specifically, the 189 
VVR calculated at 48 hours postoperatively has been shown to be a robust predictor of 190 
short-term clinical outcomes and consistently outperformed the vasoactive inotrope 191 
score (VIS) and serum lactate, which have been used as more traditional measures of 192 
postoperative disease severity [3-8].    193 
 194 
Our previous studies of the VVR have had notable limitations.  These studies have been 195 
restricted to patients less than 18 years of age who have required cardiopulmonary 196 
bypass.  Adults undergoing surgery for congenital heart disease and children undergoing 197 
cardiac surgery without cardiopulmonary bypass (e.g. systemic-to-pulmonary shunt, 198 
pulmonary artery banding, etc.) have been excluded.   Additionally, these prior reports 199 
focused only on VVR measurements obtained at admission, peak and 48 hour 200 
measurements.  Peak and 48-hour VVR measurements in particular were chosen for 201 
these initial studies because these measurements have been the focus of the majority of 202 
research on the VIS.[3-5]  The clinical utility of measurements obtained at specific 203 
postoperative time points earlier in the postoperative course has not yet been 204 
determined.  To address these gaps in what is known regarding the VVR, we sought to 205 
conduct a more inclusive prospective observational study examining the VVR score.  We 206 
postulated that the VVR would continue to be more predictive of outcomes as compared 207 
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to the VIS and serum lactate in this broader population of patients recovering from 208 
surgery for congenital heart disease.  We also sought to determine if the VVR obtained 209 
at distinct time points earlier in the postoperative period, which would have more 210 
practical clinical value, would be as predictive of postoperative outcomes as the VVR 211 
calculated at 48 hours. 212 
 213 
Patients and Methods 214 
Patient Population 215 
This prospective observational validation study was approved by the Institutional Review 216 
Board within the Office of Research Compliance at Indiana University.  Due to the 217 
observational nature of the study, consent was waived by the Institutional Review Board.  218 
All patients admitted to the cardiovascular intensive care unit (CVICU) at Riley Hospital 219 
for Children in Indianapolis, Indiana, from January 1, 2015 through June 30, 2015 were 220 
prospectively reviewed. Patients who required extracorporeal membrane oxygenation 221 
(ECMO) for the first 48 hours of CVICU admission were excluded, as their vasoactive 222 
medication regimens and ventilator requirements would not be reflective of their 223 
underlying disease severity but rather of the mechanical support provided by the 224 
extracorporeal circuit.  All other patients were followed throughout their clinical courses 225 
and included in all analyses. 226 
 227 
Data Collection 228 
Pre- and perioperative data collected included: age, anthropometric measurements at 229 
time of surgery, anatomic diagnosis and procedure performed, Society of Thoracic 230 
Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart Surgery 231 
mortality category (STAT mortality category),[9] cardiopulmonary bypass duration, aortic 232 
cross-clamp duration, duration of hypothermic circulatory arrest if used, and preoperative 233 
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serum creatinine values. All arterial blood gas and lactate measurements (which are 234 
performed simultaneously using point-of-care testing) obtained during the first 48 235 
postoperative hours were recorded daily by study personnel, along with the ventilator 236 
support at the time of each measurement, which included respiratory rate (RR), fraction 237 
of inspired oxygen (FiO2), peak inspiratory pressure (PIP), positive end expiratory 238 
pressure (PEEP), and mean airway pressure (MAP).  Patients at our institution are 239 
typically managed postoperatively with synchronized intermittent mandatory ventilation / 240 
pressure-regulated volume control, and typically extubated, at the discretion of the 241 
primary care team, from mechanical ventilator support when breathing comfortably with 242 
good gas exchange and without metabolic acidosis on the following ventilator settings: 243 
respiratory rate ≤ 10 breaths per minute, pressure support ≤ 10 cmH2O, positive end-244 
expiratory pressure ≤ 5 cmH2O, and fraction of inspired oxygen concentration ≤ 0.4.  245 
Doses of inotropic and vasopressor medications (e.g. dopamine, dobutamine, 246 
epinephrine, norepinephrine, milrinone, and vasopressin) at the time of each arterial 247 
blood gas measurement were also recorded.  Lastly, serum creatinine values obtained 248 
on admission, postoperative day 1 and postoperative day 2 were recorded.  249 
 250 
Derivation of the Vasoactive Ventilation Renal Score 251 
Throughout each patient’s hospital course, we calculated the patients’ VIS at the time of 252 
each postoperative arterial blood gas measurement.  The VIS was calculated in the 253 
following manner [3]: 254 
 255 
VIS = dopamine dose (mcg/kg/min) + dobutamine dose (mcg/kg/min) + 100 * 256 
epinephrine dose (mcg/kg/min) + 10 * milrinone dose (mcg/kg/min) + 10,000 * 257 
vasopressin dose (U/kg/min) + 100 * norepinephrine dose (mcg/kg/min).    258 
 259 
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For patients on no vasoactive support at the time of blood gas measurement, VIS 260 
equaled zero. Secondly, the ventilation index (VI) was calculated for each postoperative 261 
arterial blood gas measurement as follows [10]: 262 
 263 
VI = (Ventilator RR)*(PIP-PEEP)*PaCO2 / 1000 264 
 265 
Use of the VI, which incorporates PaCO2 rather than PaO2 into its formula, permits the 266 
inclusion of patients with mixing lesions and single ventricle anatomy in the study, as 267 
PaCO2 is less affected by intra-cardiac shunting.  For patients not requiring mechanical 268 
ventilation at the time of arterial blood gas measurement, VI equaled zero. Lastly, 269 
baseline preoperative serum creatinine was subtracted from each postoperative serum 270 
creatinine measurement (e.g. on admission, and postoperative days 1 and 2), which we 271 
labeled ∆Cr.  For patients in which postoperative serum creatinine measurements were 272 
less than or equal to baseline, we recorded ∆Cr = 0.   Creatinine was measured in 273 
mg/dL.  (For centers where creatinine is measured in mmol/L, we recommend converting 274 
to mg/dL to calculate the score as follows:  serum creatinine (mmol/dL) x 0.0113 = 275 
serum creatinine (mg/dL)). 276 
 277 
Using each of these individual measurements, we then calculated the VVR at the time of 278 
each arterial blood gas measurement as follows:  279 
 280 
VVR = VIS + VI + (∆Cr *10) 281 
 282 
VVR scores at 6, 12, 24, and 48 hours postoperatively were recorded. 283 
 284 
Statistical Analyses 285 
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Descriptive statistics are provided as medians with interquartile ranges (IQR) for 286 
continuous variables and absolute counts with percentages for categorical variables.  287 
The primary outcome of interest was hospital length of stay (LOS).  We opted to focus 288 
the study on hospital LOS because we deemed criteria for hospital discharge as 289 
compared to ICU discharge to likely be less inconsistent across centers.  Hospital LOS 290 
is also inclusive of time spent in the ICU related to unplanned readmission after transfer 291 
to the cardiology ward.   This outcome was dichotomized as upper (worst) 25th percentile 292 
versus lower 75th percentile.  Patients in the upper 25% were defined as having 293 
prolonged LOS.  Bivariate logistic regression analyses were performed to determine the 294 
individual contributions of VVR, VIS and serum lactate as predictors of LOS.  This 295 
analysis was repeated for each of the four recorded time points. Receiver operative 296 
characteristic (ROC) curves were generated and the abilities of the predictors to 297 
correctly classify LOS were compared using area under the curve (AUC) values.  AUC 298 
values for VVR at the study time points were compared using the method of DeLong, 299 
DeLong, and Clarke-Pearson as implemented by SAS.[11]   300 
 301 
Bivariate comparisons were performed for demographic and surgical characteristics of 302 
patients with and without prolonged LOS using Wilcoxon rank-sum tests, Χ-square test, 303 
or Fisher’s exact test as appropriate for individual variables. Variables that attained a 304 
bivariate significance of ≤ 0.30 and were of clinical relevance were considered for 305 
inclusion in a multivariable logistic regression model. Linearity in the logit was examined 306 
for continuous variables prior to model-building; those with evidence of non-linearity 307 
were converted to categorical variables. To obtain the best model, stepwise selection 308 
was used with a significance level of 0.3 for entry into the model, and 0.05 for staying.  309 
All statistical analyses were performed using STATA version 13 and SAS version 9.4. 310 
 311 
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Results 312 
Study Population 313 
During the study period, 168 unique patients were admitted to the cardiovascular ICU 314 
postoperatively.  Four patients required ECMO support for the first 48 postoperative 315 
hours and were excluded from analysis.  All other patients (N=164) were included in the 316 
analysis, median age 9.3 months (range: 1 day - 33 years).  A summary of the 317 
demographic and clinical characteristics of the patient cohort are shown in Table 1.  318 
Median hospital LOS, our primary outcome variable, was 8 days (IQR:  5-17.5).  319 
Prolonged LOS was therefore defined as greater than 17.5 days.  Three patients died 320 
before hospital discharge, all of which had prolonged hospital LOS prior to their deaths 321 
(range 29 - 148 days).    In addition, the hospital LOS for the four excluded patients who 322 
required ECMO support for the first 48 hours ranged from 38 to 248 days, and none of 323 
these patients died prior to hospital discharge. 324 
 325 
Median serum lactate, VIS, and VVR measurements with IQR and maximum values are 326 
presented in Table 2 for all study time points.  We obtained ROC curves via bivariate 327 
logistic regression analysis for 6, 12, 24, and 48-hour serum lactate, VIS, and VVR as 328 
predictors of prolonged LOS.  The AUC values for these models are also provided in 329 
Table 2.  Similar to our prior studies [1,2], VVR performed well and had a greater AUC 330 
than the corresponding VIS and serum lactate at each time point (P < 0.05 for all 331 
comparisons).  We also performed ROC analysis for age, weight, duration of 332 
cardiopulmonary bypass, and STAT category as predictors of prolonged LOS.  The VVR 333 
at each of the four study time points was more predictive of prolonged LOS than any of 334 
these patient variables (P < 0.05 for all comparisons).  The ROC curves for prolonged 335 
LOS and serum lactate, VIS, and VVR at 12 hours postoperatively, as well as STAT 336 
mortality category, are illustrated in Figure 2.    337 
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   338 
The AUCs for the VVR at 6, 12, 24, and 48 hours are statistically compared to each 339 
other in Supplemental Table 2.  There were no statistical differences between the ROC 340 
curves for any of the VVR time points.  In other words, the VVR at 6, 12, and 24 hours 341 
were, at the very least, as predictive as the VVR at 48 hours.  Of the four VVR 342 
measurements, the 12-hour VVR had the highest AUC, 0.93 (95% CIs: 0.89-0.97).  For 343 
this reason, the remainder of the analysis is focused on this time point.    344 
 345 
Demographic and clinical variables for patients with and without prolonged hospital LOS 346 
are compared in Table 3.  All variables with P-value <0.3 were considered for the 347 
multivariable model.  On multivariable regression analysis, the 12-hour VVR remained a 348 
strong independent predictor of prolonged LOS.  Specifically, with each increase of 1 in 349 
a patient’s 12-hour VVR score, the odds of a prolonged LOS increased by 15% (OR: 350 
1.15, 95% CI: 1.10, 1.20).  Other variables that were independently associated with 351 
prolonged LOS were the presence of non-cardiac anatomic abnormalities and the use of 352 
inhaled nitric oxide.  The remaining variables that were significant on bivariate analysis, 353 
namely age, weight, STAT category 4 or 5, duration of cardiopulmonary bypass, and 354 
admission lactate, were not significant on multivariable analysis and did not appreciably 355 
affect the model.  Delayed sternal closure and the need for CPR were not included in the 356 
multivariable analysis because of the small number of patients within the study who had 357 
these postoperative complications.  The best multivariable model for prolonged LOS 358 
including the 12-hour VVR, inhaled nitric oxide use, and non-cardiac anatomic 359 
abnormalities is presented in Table 4.  The AUC for the model was 0.94 (95% CI: 0.91, 360 
0.98).  ROC curves for the model and its individual components are shown in Figure 2. 361 
 362 
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To simplify the interpretation and use of the 12-hour VVR, we dichotomized the variable 363 
into high and low. A 12-hour VVR cutoff value of 25 was chosen to maximize total 364 
accuracy and minimize weighted error ratios, and this cutoff correctly classified 90% of 365 
patients.  Patients with 12-hour VVR greater than or equal to 25 were therefore defined 366 
as having a high VVR score.  On multivariable logistic regression analysis, after 367 
adjustment for the presence of inhaled nitric oxide and non-cardiac anatomic 368 
abnormalities, high VVR at 12 hours remained strongly associated with prolonged LOS 369 
(odds ratio: 31; 95% CI: 10 - 90).  370 
 371 
Comment 372 
We have further validated the VVR as a multi-organ system severity of illness index for 373 
patients recovering from surgery for congenital heart disease.  We have now 374 
demonstrated that the VVR strongly predicts hospital length of stay, more so than the 375 
VIS and serum lactate, in a patient population that not only includes children requiring 376 
cardiopulmonary bypass but also includes children undergoing procedures without 377 
cardiopulmonary bypass and adults with congenital heart disease.  The patients included 378 
in this study reflect the postoperative patient populations at many centers, where adults 379 
undergoing surgery for congenital heart disease are commonly cared for within pediatric 380 
cardiovascular ICU’s [12,13].   The greater heterogeneity of the patient population in this 381 
study has increased the strength and practicality of the VVR.   382 
 383 
In our prior work, the VVR calculated at 48 hours was superior to admission and peak 384 
VVR measurements.[1,2]  In fact, admission measurements performed poorly.  This 385 
finding was not surprising, as vasoactive and ventilator support upon CVICU admission 386 
are likely less reflective of organ dysfunction and illness severity but rather more related 387 
to the dynamic processes that occur after cessation of cardiopulmonary bypass and 388 
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during transport to the CVICU.  Likewise, the support upon admission may also be the 389 
peak support, which will negatively affect the strength of peak VVR measurements.  We 390 
have now demonstrated that the VVR calculated at specific time points earlier in than 48 391 
hours postoperatively can also reliably predict clinical outcome in children recovering 392 
from cardiac surgery.  Specifically, patients with a VVR score greater than or equal to 25 393 
at the 12 hours postoperatively were 31 times more likely to have a prolonged length of 394 
stay as compared to patients with lower VVR scores.  This ability to provide important 395 
prognostic data earlier in the postoperative course further increases the functionality of 396 
the VVR.   397 
 398 
The advantages of the VVR as compared to the VIS and serum lactate, as we have 399 
discussed in our prior work [1,2], should be intuitive to physicians caring for these 400 
children, as the VVR likely captures that subset of patients who have may have 401 
preserved hemodynamic integrity yet have significant burden of disease from 402 
postoperative lung or kidney injury.  The additional components of the VVR, though on 403 
the surface may seem cumbersome to some, can be obtained from routinely available 404 
bedside data and the score can be quantitated with a simple calculator.  Incorporation of 405 
VVR calculation into the electronic medical record could further enhance its utility.  If 406 
available to physicians at the bedside, the 12-hour VVR has several potential clinical 407 
applications.  The 12-hour VVR could provide a reliable estimate of illness severity, give 408 
parents and families realistic expectations of their child’s postoperative course, or 409 
potentially assist with triage CVICU resources.    Additionally, the 12-hour VVR could 410 
help stratify potential research subjects or assist with propensity score matching.  411 
Further validation in a multi-center data set should, however, be performed before 412 
widespread application is recommended. 413 
 414 
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This study also found that the use of inhaled nitric oxide and the presence of non-cardiac 415 
anatomic abnormalities had an effect on hospital LOS that was independent of the organ 416 
dysfunction quantitated by the 12-hour VVR.  Use of inhaled nitric oxide, in many cases, 417 
represents an escalation of cardiopulmonary support beyond traditional vasoactive 418 
medications and ventilatory support.  It is therefore somewhat intuitive that its use is 419 
associated with prolonged LOS, independent of the VVR.  Likewise, the presence of 420 
non-cardiac anatomic abnormalities such as airway anomalies or gastrointestinal defects 421 
(e.g. intestinal malrotation, imperforate anus, Hirschsprung’s disease) would not be 422 
accounted for by the VVR yet could surely prolong LOS, especially if surgical 423 
interventions were needed to address those abnormalities.  Though the VVR at 12 hours 424 
in and of itself was a solid predictor of prolonged LOS, addition of these important 425 
variables further elevated the strength of our predictive model (Figure 2). 426 
 427 
There are some limitations that must be noted.  These data come from a single center, 428 
which limits their generalizability.  The initial work on the VVR was however completed at 429 
a different center [1,2] and thus the VVR has now been validated as a predictor of 430 
postoperative outcome at two different institutions with different cardiac surgeons and 431 
varying practices.  A multi-center validation study is the next step.  Larger studies should 432 
also determine if the VVR has the ability to predict additional outcomes (most important 433 
of which is postoperative mortality), and whether other variables such as delayed sternal 434 
closure or the need for CPR have an effect on outcome independent of the VVR.  We 435 
acknowledge that the VVR cannot reliably be calculated for patients requiring ECMO 436 
support, though the need for ECMO in these patients, in and of itself, is considered by 437 
most clinicians to be a reliable marker of disease severity.  Indeed, all four patients who 438 
were excluded due to ECMO support would be characterized as having prolonged LOS.  439 
Also, no patients in our cohort required peritoneal dialysis or continuous renal 440 
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replacement therapy within the first 48 hours postoperatively, but either modalities could 441 
also affect the reliability of the score.  Finally, the VVR remains affected by limitations 442 
previously noted in the VIS [3] - it does not assess the importance of the individual 443 
components of the VIS, and vasoactive medication administration as well as the degree 444 
of mechanical ventilator support were not under protocol and so may have been affected 445 
by variation in physician practice.  446 
 447 
Conclusions 448 
We have further validated the utility of the VVR score after surgery for congenital heart 449 
disease.  The VVR calculated at 12 hours postoperatively could be a valuable and 450 
potentially powerful clinical tool to predict important postoperative outcomes in this 451 
patient population.  452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
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Figure Legends 519 
Figure 1:  Receiver Operating Characteristic (ROC) curves for prolonged hospital length 520 
of stay and serum lactate (green), vasoactive-inotrope score (VIS) (red), vasoactive-521 
ventilation-renal (VVR) score at 12 hours postoperatively (blue), along with STAT 522 
category (orange).  The AUC was greatest for the VVR at 12 hours postoperatively, 523 
P<0.001 for all comparisons.  524 
Figure 2: Receiver Operating Characteristic (ROC) curves for prolonged hospital length 525 
of stay and the multivariable model (solid blue line) and its individual components 526 
(dashed lines): vasoactive-ventilation-renal (VVR) score at 12 hours postoperatively 527 
(red), inhaled nitric oxide (purple), and non-cardiac anatomic abnormalities (green).  528 
Area under the curve for the multivariable model was 0.94 (95% CI: 0.91 – 0.98). 529 
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Video Legend 540 
Video:  Dr. Mastropietro explains the inception of the vasoactive-ventilation-renal score 541 
as an index of disease severity for infants and children who undergo cardiovascular 542 
surgery, and comments on the significance of the findings presented in their latest study. 543 
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Tables 
Table 1: Patient Demographic Characteristics 
Characteristic All Patients (n=164) 
Age (months) 9.3 (2.6 – 57.8) 
Male (n) 102 (62%) 
Weight (kg) 7.8 (4.6 – 17.8) 
Race (n) 
    Caucasian  
    African American 
    Asian 
    Other 
 
131 (80%) 
23 (14%) 
7 (4%) 
3 (2%) 
Genetic / chromosomal abnormalities (n) 
 Trisomy 21 
 Other 
35 (21%)                                                                   
17 (10%) 
18 (11%) 
Non-cardiac anatomic abnormalities (n) 30 (18%) 
STAT category (n) 
 1 
 2 
 3 
 4 
 5 
 Other 
 
52 (32%) 
41 (25%) 
31 (19%) 
31 (19%) 
7 (4%) 
2 (1%) 
Preoperative creatinine (mg/dL) 0.35 (0.29 - 0.50) 
Cardiopulmonary bypass duration (min) 88 (59 -136) 
Aortic cross clamp duration (min) 42 (15 – 66) 
Delayed sternal closure (n) 16 (10%) 
Postoperative inhaled nitric oxide use (n) 27 (16%) 
Admission lactate (mg/dL) 2.0 (1.3 - 2.9) 
Postoperative CPR (n) 6 (4%) 
CPR: cardiopulmonary resuscitation; STAT: Society of Thoracic Surgeons-European Association for 
Cardio-Thoracic Surgery Congenital Heart Surgery mortality category 
Data represented as absolute counts (%) or median (interquartile range) 
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Table 2: Relationship between postoperative measurements and prolonged LOS 
Postoperative Variables Median (IQR) Maximum AUC (95% CI) 
6-hours:    
 Lactate (mg/dL) 1.3 (0.8 - 2.6) 9.2 0.75 (0.67 - 0.84) 
 VIS 0 (0 - 5) 15.5 0.81 (0.74 - 0.88) 
 VVR 5.2 (0.6 - 24.3) 96 0.93 (0.89 - 0.97) 
12-hours:    
 Lactate (mg/dL) 1.1 (0.7 - 1.9) 9.7 0.78 (0.71 - 0.86) 
 VIS 0 (0 - 5) 16 0.81 (0.73 - 0.88) 
 VVRa 3.5 (0.2 - 24.6) 75 0.93 (0.89 - 0.97) 
24-hours:    
 Lactate (mg/dL) 0.9 (0.7 - 1.4) 5.4 0.61 (0.52 - 0.71) 
 VIS 0 (0 - 5) 17 0.84 (0.77 - 0.91) 
 VVR 1.7 (0 - 20.9) 64 0.91 (0.84 - 0.97) 
48-hours:    
 Lactate (mg/dL) 0.85 (0.6 - 1.3) 5.4 0.55 (0.45 - 0.65) 
 VIS 0 (0 - 4.5)  17.5 0.83 (0.76 - 0.91) 
 VVR 0.5 (0-11.1) 64 0.89 (0.81 - 0.96) 
Age (months) 9.3 (2.6 - 57.8) 33 years 0.78 (0.70 - 0.87) 
Weight (kg) 7.8 (4.6 -17.8) 100 0.80 (0.72 - 0.88) 
STAT category 2 (1 - 3) 5 0.79 (0.72 - 0.87) 
CPB duration (min) 87.5 (59 -136) 345 0.66 (0.55 - 0.77) 
a AUC for VVR at 12 hours was 0.933, slightly greater than AUC for VVR at 6 hours of 0.929 
AUC: Area under the receiver operating characteristic curve; CPB: cardiopulmonary bypass; CI: 
confidence interval; IQR: interquartile range; LOS: hospital length of stay; STAT: Society of Thoracic 
Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart Surgery mortality 
category; VIS: vasoactive inotrope score; VVR: vasoactive-ventilation-renal score 
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Table 3.  Bivariate Analysis Comparing Patients With and Without Prolonged LOS 
Characteristic Prolonged LOS 
(n=41) 
No Prolonged 
LOS (n=123) 
P-value 
Age (months) 1.5 (0.3 - 6.5) 11.5 (6.3 - 80) <0.001 
Male (n) 28 (68%) 74 (60%) 0.35 
Weight (kg) 4.2 (3.4 - 5.5) 8.5 (6.1 - 22.3) < 0.001 
Genetic abnormalities (n) 7 (17%) 28 (23%) 0.44 
NCAA (n) 13 (32%) 17 (14%) 0.01 
STAT category 4 or 5 (n) 21 (51%) 17 (14%) <0.001 
Preoperative creatinine (mg/dL) 0.35 (0.29 - 0.48) 0.35 (0.29 - 0.51) 0.42 
CPB Duration (min) 129 (78 - 173) 82 (56 - 122) 0.002 
Aortic cross clamp duration (min) 53 (22 - 70) 36 (14 - 60) 0.13 
Delayed sternal closure (n) 15 (37%) 1 (1%) <0.001 
Postoperative iNO use (n) 19 (46%) 8 (7%) <0.001 
Admission lactate (mg/dL) 2.3 (1.7 - 5) 1.9 (1.3 - 2.7) 0.004 
VVR at 12 hours 31 (27 - 40) 1 (0 - 11) <0.001 
CPB: Cardiopulmonary bypass; iNO: inhaled nitric oxide; NCAA: non-cardiac anatomic abnormalities; 
STAT: Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart 
Surgery mortality category; VVR: vasoactive-ventilation-renal score 
Data represented as absolute counts (%) or median (interquartile range) 
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Table 4.  Multivariable Regression Analysis for Predictors of Prolonged LOS 
Parameter Estimate SE P-value Odds Ratio (95% CI) 
Intercept -4.20 0.64 <0.0001 - 
12-hour VVR 0.14 0.02 <0.0001 1.15 (1.10, 1.20) 
Inhaled nitric oxide 1.50 0.71 0.033 4.50 (1.13, 17.99) 
Non-cardiac anatomic 
abnormalities  
1.54 0.73 0.034 4.67 (1.13, 19.34) 
CI:  Confidence interval; LOS: length of stay; SE:  standard error; VVR: vasoactive-ventilation-renal score 
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Supplemental Table 1.  Cardiovascular Surgical Procedures Organized by STAT Mortality 
Categories 
Primary surgical procedure All Patients (N=164) 
STAT Category 1 
  Repair, atrial septal defect 
  Repair, ventricular septal defect 
  Repair, Tetralogy of Fallot 
  Pulmonary valve replacement 
  Lateral tunnel Fontan operation 
  Repair, partial atrioventricular canal defect 
  Other 
STAT Category 2 
  Repair, coarctation of the aorta 
  Aortic valvuloplasty 
  Repair, Tetralogy of Fallot 
  Extracardiac Fontan operation 
  Bidirectional Glenn operation 
  Other 
STAT Category 3  
  Arterial Switch procedure (d-TGA w/IVS) 
  Hemi-Fontan operation 
  AV-Canal 
  Repair, pulmonary atresia w/VSD 
  Right ventricle-to-pulmonary artery conduit 
  Other 
STAT Category 4 
  Systemic-to-pulmonary artery shunt 
  Orthotopic heart transplant 
  Repair, total anomalous pulmonary venous return 
  Arterial switch procedure (d-TGA w/VSD) 
  Pulmonary artery banding  
  Other 
STAT Category 5 
  Norwood operation 
  Damus-Kaye Stanzel operation  
52 (32%) 
9 
13 
9 
7 
4 
3 
7 
41 (25%) 
8 
6 
4 
3 
3 
17 
31 (18%) 
5 
6 
5 
5 
4 
6 
31 (19%) 
7 
5 
5 
2 
3 
9 
7 (4%) 
6 
1 
d-TGA: d-transposition of the great arteries; IVS: intact ventricular septum; VSD: ventricular 
septal defect 
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Supplemental Table 2. Statistical Comparison for Area under the Curve Values for the 
Vasoactive-Ventilation-Renal (VVR) score and Prolonged Length of Stay at 6, 12, 24, and 48 
hours. 
 
Contrast Estimate SE 95% Wald CL Chi-Square P-value 
VVR 6 hr - VVR 12 hr -0.00366 0.0105 -0.0242 0.0169 0.1213 0.73 
VVR 6 hr - VVR 24 hr 0.0210 0.0252 -0.0283 0.0704 0.6978 0.40 
VVR 6 hr - VVR 48 hr 0.0403 0.0280 -0.0145 0.0952 2.0787 0.15 
VVR 12 hr - VVR 24 hr 0.0247 0.0232 -0.0208 0.0702 1.1335 0.29 
VVR 12 hr - VVR 48 hr 0.0440 0.0282 -0.0112 0.0992 2.4421 0.12 
VVR 24 hr - VVR 48 hr 0.0193 0.0197 -0.0192 0.0578 0.9656 0.33 
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